Keyphrases
Denmark
100%
Confidence Interval
80%
Meta-analysis
46%
Randomized Controlled Trial
44%
Type 2 Diabetes Mellitus (T2DM)
38%
Hazard Ratio
35%
Type 1 Diabetes Mellitus (T1DM)
33%
Systematic Meta-analysis
32%
Risk Factors
32%
National Cohort Study
31%
Placebo
31%
Odds Ratio
28%
High Risk
27%
Randomized Clinical Trial
27%
Type I Diabetes
26%
Copenhagen
25%
Quality of Life
22%
Diabetes
22%
Randomized Trial
21%
Body Mass Index
20%
Europe
20%
Comorbidity
19%
Rheumatoid Arthritis
19%
All-cause Mortality
19%
Atrial Fibrillation
19%
Heart Failure
19%
Obesity
18%
Asthma
18%
COVID-19
17%
Clinical Outcomes
17%
Type 2 Diabetic Patients
17%
Clinical Trials
17%
Cardiovascular Disease
16%
Multiple Sclerosis
16%
Schizophrenia
16%
Magnetic Resonance Imaging
16%
Healthy Controls
16%
Tumor
16%
Prospective Cohort Study
16%
Myocardial Infarction
16%
Cardiovascular Risk
15%
Bipolar Disorder
15%
Register Study
15%
Older Adults
14%
Inflammation
14%
Glucagon-like
14%
Physical Activity
14%
Breast Cancer
14%
Incidence Rate
14%
Chronic Obstructive Pulmonary Disease
13%
Inflammatory Bowel Disease
13%
Hospitalization
13%
Overall Survival
13%
Health-related Quality of Life
13%
Out-of-hospital Cardiac Arrest
12%
Adverse Events
12%
Migraine
12%
Population-based Study
12%
Clinical Practice
12%
Randomized Placebo-controlled Trial
12%
Colorectal Cancer
11%
Non-associated
11%
AIMS™
11%
Danish Population
11%
During Pregnancy
11%
Chronic Kidney Disease
11%
Cardiovascular Mortality
11%
Pregnant Women
10%
Atopic Dermatitis
10%
Low Risk
10%
Healthcare Professionals
10%
Healthy Individuals
10%
Population-based
10%
Genome-wide Association Study
10%
Hemoglobin A1c (HbA1c)
10%
Chemotherapy
10%
Ultrasound
10%
Blood Pressure
10%
Genotype
9%
Population-based Cohort Study
9%
Alzheimer's Disease
9%
Headache
9%
Positron Emission Tomography
9%
Skeletal muscle
9%
Cancer Patients
9%
Psoriasis
9%
Weight Loss
9%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
9%
Computed Tomography
9%
Intensive Care Unit
9%
Patient-reported Outcomes
9%
Insulin
9%
No Significant Difference
8%
Embase
8%
Adult Patients
8%
Acute Myocardial Infarction
8%
ST-elevation Myocardial Infarction (STEMI)
8%
Clinically Significant
8%
Blood Samples
8%
Ischemic Heart Disease
8%
Medicine and Dentistry
Cohort Analysis
64%
Disease
61%
Systematic Review
54%
Randomized Controlled Trial
40%
Symptom
36%
Malignant Neoplasm
35%
Meta-Analysis
35%
Neoplasm
32%
Prevalence
31%
Diabetes
31%
Diagnosis
30%
Quality of Life
29%
Maturity Onset Diabetes of the Young
28%
Placebo
28%
Magnetic Resonance Imaging
27%
Hazard Ratio
27%
Infection
25%
Biological Marker
24%
Cardiovascular System
23%
Breast Cancer
21%
Apoplexy
20%
Adverse Event
20%
Heart Failure
20%
Cardiovascular Disease
20%
Clinical Trial
19%
Randomized Clinical Trial
19%
Odds Ratio
18%
Insulin Dependent Diabetes Mellitus
18%
Pediatrics
17%
Human Immunodeficiency Virus
17%
Body Mass Index
17%
Surgery
16%
Childbirth
16%
Injury
16%
Observational Study
16%
COVID-19
15%
Atrial Fibrillation
15%
Cross Sectional Study
15%
Drug Therapy
14%
Recurrent Disease
13%
Population
13%
Overall Survival
12%
Rheumatoid Arthritis
12%
Diabetes Mellitus
11%
Radiation Therapy
11%
Prospective Cohort Study
11%
Clinician
11%
Patient-Reported Outcome
11%
Computer Assisted Tomography
10%
Physical Activity
10%
Asthma
10%
Rehabilitation Engineering
10%
Intensive Care Unit
10%
Prostate Cancer
10%
Myocardial Infarction
10%
Chronic Obstructive Pulmonary Disease
10%
Health Care Cost
10%
Out of Hospital Cardiac Arrest
10%
Adolescent
10%
Proportional Hazards Model
10%
Migraine
10%
Patient with Type 2 Diabetes
9%
Ovarian Cancer
9%
Blood Pressure
9%
Arm
9%
Bleeding
9%
Biopsy
9%
Surgeon
9%
Positron Emission Tomography
9%
Percutaneous Aortic Valve Replacement
9%
All Cause Mortality
9%
Prospective Study
9%
Chronic Kidney Disease
8%
Inflammatory Bowel Disease
8%
Health Care
8%
Skeletal Muscle
8%
Logistic Regression Analysis
8%
Headache
8%
Outpatient
8%
Cardiovascular Risk
8%
Ischemic Heart Disease
8%
Combination Therapy
8%
Colorectal Cancer
8%
Cohort Effect
7%
Positron Emission Tomography-Computed Tomography
7%
Hemodynamic
7%
Lung Cancer
7%
Case-Control Study
7%
Resuscitation
7%
Multiple Sclerosis
7%
Wart Virus
7%
Coronary Artery Disease
7%
Exercise
7%
Hemoglobin A1c
7%
Nodular Melanoma
7%
Glucagon Like Peptide 1
7%
Cancer
7%
Diseases
7%
In Vitro
6%
Antibiotics
6%